GR58469B - Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides - Google Patents

Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides

Info

Publication number
GR58469B
GR58469B GR51742A GR760151742A GR58469B GR 58469 B GR58469 B GR 58469B GR 51742 A GR51742 A GR 51742A GR 760151742 A GR760151742 A GR 760151742A GR 58469 B GR58469 B GR 58469B
Authority
GR
Greece
Prior art keywords
arylacetamides
piperidinyl
aryl
novel
Prior art date
Application number
GR51742A
Other languages
Greek (el)
Inventor
S Sanczuk
H Hubert
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of GR58469B publication Critical patent/GR58469B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR51742A 1975-09-23 1976-09-21 Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides GR58469B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61513175A 1975-09-23 1975-09-23
US71375676A 1976-08-12 1976-08-12

Publications (1)

Publication Number Publication Date
GR58469B true GR58469B (en) 1977-10-14

Family

ID=27087421

Family Applications (1)

Application Number Title Priority Date Filing Date
GR51742A GR58469B (en) 1975-09-23 1976-09-21 Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides

Country Status (29)

Country Link
JP (1) JPS6016417B2 (en)
AT (1) AT363935B (en)
AU (1) AU510029B2 (en)
BG (1) BG27543A3 (en)
CA (1) CA1068271A (en)
CH (1) CH628623A5 (en)
CS (1) CS222663B2 (en)
DE (1) DE2642856A1 (en)
DK (1) DK150478C (en)
ES (1) ES451768A1 (en)
FI (1) FI61482C (en)
FR (1) FR2325377A1 (en)
GB (1) GB1539473A (en)
GR (1) GR58469B (en)
HU (1) HU172964B (en)
IE (1) IE43802B1 (en)
IL (1) IL50522A (en)
IT (1) IT1073893B (en)
LU (1) LU75837A1 (en)
NL (1) NL187267C (en)
NO (1) NO147672C (en)
NZ (1) NZ181972A (en)
PH (1) PH12497A (en)
PL (2) PL117323B1 (en)
PT (1) PT65631B (en)
RO (1) RO70079A (en)
SE (1) SE427839B (en)
SU (1) SU747424A3 (en)
YU (1) YU39973B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA765684B (en) * 1975-09-23 1978-04-26 Janssen Pharmaceutica Nv Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
JPS62260786A (en) * 1986-05-08 1987-11-13 株式会社ヘキトク Line system for manufacturing smoked roof tile
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Fast Dissociting Dopamine 2 Receptor Antagonists
JO2642B1 (en) 2006-12-08 2012-06-17 جانسين فارماسوتيكا ان. في Fast Dissociating Dopamine 2 Receptor Antagonists
JO2849B1 (en) 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Fast -Dissociating Dopamine 2 Receptor Antagonists
AU2008240727C1 (en) * 2007-04-23 2013-10-03 Janssen Pharmaceutica N.V. Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
CN101663292A (en) 2007-04-23 2010-03-03 詹森药业有限公司 4-alkoxypyridazine derivatives as quick dissociated dopamine 2 receptor antagonists
CA2682671C (en) 2007-04-23 2015-11-17 Janssen Pharmaceutica N.V. Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists
CN102159554B (en) 2008-07-03 2014-09-24 詹森药业有限公司 Substituted 6- (1-piperazinyl) -pyridazines as 5-ht6 receptor antagonists
LT2307374T (en) 2008-07-31 2017-04-25 Janssen Pharmaceutica Nv Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists

Also Published As

Publication number Publication date
FR2325377B1 (en) 1980-04-18
HU172964B (en) 1979-01-28
PH12497A (en) 1979-04-05
RO70079A (en) 1982-10-26
LU75837A1 (en) 1977-05-04
JPS5239683A (en) 1977-03-28
FI61482C (en) 1982-08-10
NZ181972A (en) 1978-07-28
CH628623A5 (en) 1982-03-15
AU510029B2 (en) 1980-06-05
DE2642856C2 (en) 1990-06-21
AU1787876A (en) 1978-03-23
PL192578A1 (en) 1979-02-26
ES451768A1 (en) 1978-05-01
FI762698A (en) 1977-03-24
NO763054L (en) 1977-03-24
JPS6016417B2 (en) 1985-04-25
BG27543A3 (en) 1979-11-12
SU747424A3 (en) 1980-07-23
CS222663B2 (en) 1983-07-29
NO147672C (en) 1983-05-25
FI61482B (en) 1982-04-30
YU39973B (en) 1985-06-30
PL117323B1 (en) 1981-07-31
IL50522A (en) 1979-09-30
NL187267B (en) 1991-03-01
IE43802B1 (en) 1981-06-03
SE427839B (en) 1983-05-09
NL7610513A (en) 1977-03-25
DK150478C (en) 1987-10-05
YU233676A (en) 1983-01-21
CA1068271A (en) 1979-12-18
IE43802L (en) 1977-03-23
IT1073893B (en) 1985-04-17
GB1539473A (en) 1979-01-31
PT65631A (en) 1976-10-01
ATA702976A (en) 1981-02-15
PT65631B (en) 1978-07-05
SE7610501L (en) 1977-03-24
DK427876A (en) 1977-03-24
NL187267C (en) 1991-08-01
DE2642856A1 (en) 1977-03-24
FR2325377A1 (en) 1977-04-22
DK150478B (en) 1987-03-09
IL50522A0 (en) 1976-11-30
NO147672B (en) 1983-02-14
AT363935B (en) 1981-09-10

Similar Documents

Publication Publication Date Title
JPS5188229A (en) Fukushakino kankodoramugaidosochi
JPS5589279A (en) Novel dibenzopyrans
PT65688A (en) Novel 1-benzazolylalkyl-4-substituted-piperidines
AU1175076A (en) Indolylalkylpiperidines
AU1271076A (en) Push-toy
GR58469B (en) Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
AU1169176A (en) Pyrimidinylureas
AU1390276A (en) Anthraquinone-bis-amidines
CS188141B2 (en) Ski-brake
AU1804476A (en) Phenylbenzofurans
ZA765684B (en) Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
AU1804276A (en) 3-phenylbenzofurans
AU1261376A (en) Diarylbutanolamines
JPS5233692A (en) Novel cephlosporin
JPS5589280A (en) Novel dibenzopyrans
AU1616876A (en) Cloches
AU1100476A (en) Electropaints
AU1105976A (en) 5-nitrothiazolylimidazolidine
AU1715276A (en) Phenylsulfenylpiperazines
CS189776A2 (en) Zpusob regenerace paladiovych katalyzatoru
JPS51106141A (en) Kinzokutonoshiitoni mokumesonotanoshimamoyoo tososuruhoho
JPS51110779A (en) Puresuniokeru fuiido baajidochakudatsusochi
JPS51104784A (en) Jitenshano ritsutaichushasochi
JPS5188513A (en) Bokakenzaino seizohoho
JPS51109601A (en) Rimukarataiyao bunrisurusochi